Skip to main content
SpringerLink
Log in

Ramelteon

TAK 375

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Takeda Pharmaceuticals North America. Takeda Submits New Drug Application for Ramelteon, an Investigational Sleep Drug. Media Release: 24 Sep 2004. Available from URL: http://www.tpna.com

    Google Scholar 

  2. Takeda Pharmaceuticals North America. Takeda Pharmaceuticals North America Shares Early Stage Data on Sleep Compound, TAK-375. Media Release: 21 May 2003. Available from: URL http://www.takedapharm.com

    Google Scholar 

  3. Stubbs CM, Karim A. Safety, pharmacokinetics, and pharmacodynamics of TAK-375 in healthy adults. American Psychiatric Association 2003 Annual Meeting: Syllabus and Proceedings Summary: 25–26, 17 May 2003

    Google Scholar 

  4. Stevenson S, Bryson S, Amakye D, et al. Study to investigate the absolute bioavailability of a single oral dose of ramelteon (TAK-375) in healthy male subjects. Clinical Pharmacology and Therapeutics 75: 22, No. 2, Feb 2004

    Google Scholar 

  5. Miyamoto M, Nishikawa H, Ohta H. et al. Pharmacological effects of TAK-375, a ML1-selective melatonin receptor agonist, in experimental animals. International Journal of Neuropsychopharmacology 3 (Suppl. 1): 213, Jul 2000

    Google Scholar 

  6. Miyamoto M, Nishikawa H, Hirai K, et al. Sleep-promoting action and pharmacological effects of TAK-375, a novel ML1-selective melatonin receptor agonist, in experimental animals. Japanese Journal of Pharmacology 85 (Suppl. I): 257 (plus poster), 2001

    Google Scholar 

  7. Kato K, Uchikawa O, Fukatsu K, et al. Neuropharmacological properties of TAK-375, a novel ML1-seleceive melatonin receptor agonist. International Journal of Neuropsychopharmacology 3 (Suppl. 1): 214–215, Jul 2000

    Google Scholar 

  8. Kato K, Hirai K, Uchikawa O, et al. Neuropharmacological properties of TAK-375, a novel melatonin ML1 receptor agonist. Japanese Journal of Pharmacology 85 (Suppl. I): 257 (plus poster), 2001

    Google Scholar 

  9. Yukuhiro N, Kimura H, Nishikawa H, et al. Effects of TAK-375, a novel melatonin receptor agonist, on sleep in freely moving monkeys. International Journal of Neuropsychopharmacology 3 (Suppl. 1): 214, Jul 2000

    Google Scholar 

  10. Yukuhiro N, Nishikawa H, Kimura H, et al. Effects of TAK-375, a novel melatonin receptor agonist, on sleep in freely moving monkeys at nighttime. Japanese Journal of Pharmacology 85 (Suppl. I): 257 (plus poster), 2001

    Google Scholar 

  11. Simpson R. News from the APSS meeting. Inpharma 1402: 10–11, 30 Aug 2003

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramelteon. Drugs in R&D 6, 186–188 (2005). https://doi.org/10.2165/00126839-200506030-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200506030-00008

Keywords

Search

Navigation